IBio Announces Acquisition Of Fabry Disease Orphan Drug Designation And Development Program
Pharma Industry / Biotech Industry | 
acquisition, announces, designation, development, disease, drug, fabry, ibio, orphan, program
The New Pharmacovigilance Legislation Will Impact US And European Drug Manufacturers
The Pharmacovigilance Legislation Will Come into Effect in July As the European Medicines Agency's new PV (pharmacovigilance) Legislation implementation date of July 2012 approaches, US and European pharmaceutical and biotech companies need to ask themselves if they are ready for the changes that lie ahead, says Paul Beninger, ...
PETA Grant Enables Scientists To Guide Chinese Officials In Non-Animal Test Use
Chinese officials are in the final stages of approving the use of the country's very first non-animal test method for cosmetics ingredients, thanks to guidance from scientists funded by PETA. The 3T3 Neutral Red Uptake Phototoxicity Assay, which tests chemicals for their potential toxicity when they come into contact with ...
Bacterial Contamination Found In Pharmacy Robots
Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. During a routine screening in 2010, personnel at Wake Forest Baptist Medical Center ...
Improving Quality Of Life For Lab Mice Leads To Better Science
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine. Laboratory mice, ...
E.coli Bacteria Help Produce Faster And Cheaper Medications
A discovery published in the March 25 issue of Nature Chemical Biology reveals that biomolecular engineers from Cornell University have discovered that Escherichia coli, a bacteria that is considered to be a severe threat in terms of food safety by restaurateurs, grocers and consumers, is in fact, a friendly bacteria. ...
Bioorthogonal Chemistry – Making Drugs Inside Patients – And More
The traditional way of making medicines from ingredients mixed together in a factory may be joined by a new approach in which doctors administer the ingredients for a medicine separately to patients, and the ingredients combine to produce the medicine inside patients' bodies. That's one promise from an emerging new ...
Nanopills Release Drugs Directly From The Inside Of Cells
UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria. Even though these inclusion bodies traditionally have been an obstacle in the industrial production of soluble enzymes and biodrugs, they ...